Berbamine prevents SARS-CoV-2 entry and transmission
Authors:
Open Access
- 8 November 2024
- Vol. 27 (12) , 111347
Abstract
No abstract availableKeywords
Funding Information
- Biotechnology Industry Research Assistance Council (BT/CS0100/06/22)
- Biotechnology Industry Research Assistance Council (BT/CS0054/05/21)
- National Institute of Allergy and Infectious Diseases
- India Diabetes Research Foundation (SARS-CoV-2)
- Translational Health Science and Technology Institute
This publication has 83 references indexed in Scilit:
- SARS‐CoV‐2 infection induces thymic atrophy mediated by IFN‐γ in hACE2 transgenic miceEuropean Journal of Immunology, 2024
- Fangchinoline inhibits SARS-CoV-2 and MERS-CoV entryAntiviral Research, 2023
- Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivityMedical Microbiology and Immunology, 2022
- Characterizing (un)binding mechanism of USP7 inhibitors to unravel the cause of enhanced binding potencies at allosteric checkpointProtein Science, 2022
- Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoproteinActa Pharmaceutica Sinica B, 2022
- Animal models of SARS-CoV-2 transmissionCurrent Opinion in Virology, 2021
- SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory TractCell, 2020
- Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV)Clinical Microbiology Newsletter, 2014
- Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichmentsJournal of Computer-Aided Molecular Design, 2013
- The VSGB 2.0 model: A next generation energy model for high resolution protein structure modelingProteins: Structure, Function, and Bioinformatics, 2011